http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2160075-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9d72c1e1c4602fdce8d7c413d03de79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fca6426e50f5a2fa20556ab3f33b548
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec6fa9daa33fc7360e170e6511343eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8682243d917024079114f90bf6837d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503977b9a8495053945ec430653a8bb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6853fab1e3c5fd7c4e03171f853f6611
publicationDate 2000-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2160075-C2
titleOfInvention Method for treating the cases of recurrent hemophthalmia edematous hemorrhagic forms of diabetic retinopathy
abstract FIELD: medicine. SUBSTANCE: method involves injecting deoxygenized perfluororganic compound into the vitreous body cavity. The perfluororganic compound deoxygenation is carried out immediately before administration by letting pure nitrogen bubble through it during 5.0 min. EFFECT: enhanced effectiveness of treatment course; reduced risk of traumatic complications.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2521832-C2
priorityDate 1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947

Total number of triples: 21.